Status | Study |
Terminated |
Study Name: IGF-1, IGFBP3, ALS Normative Ranges in Healthy Pediatric Spanish Population Condition: IGF-1 Deficiency Date: 2012-08-22 |
Recruiting |
Study Name: European Increlex® (Mecasermin [rDNA Origin] Injection) Growth Forum Database - IGFD Registry Condition: IGF1 Deficiency Date: 2009-04-30 Interventions: Drug: Increlex® Increlex® (mecasermin [rDNA origin] injection), 10 mg/ml solution for injectio |
Terminated |
Study Name: rhGH and rhIGF-1 Combination Therapy in Children With Short Stature Associated With IGF-1 Deficiency Condition: Insulin-like Growth Factor-1 Deficiency Date: 2007-12-10 Interventions: Drug: NutropinAq® (Somatropin [rDNA origin]) |
Terminated |
Study Name: Treatment of Children and Adolescents With Growth Failure Associated With Primary IGF-1 Deficiency Condition: Growth Disorders Date: 2006-05-26 Interventions: Drug: rh IGF-1 (mecasermin) Patients from untreated arm for prior study MS301 (NCT00125164) were randomi |
Completed |
Study Name: Recombinant Human Insulin-Like Growth Factor (rhIGF-1) Treatment of Short Stature Associated With IGF-1 Deficiency Condition: Insulin-Like Growth Factor-1 Deficiency Growth Disorders Date: 2005-07-27 Interventions: Drug: rhIGF-1 (mecasermin) for a period of 86 weeks once a day rhIGF-1 injections |
Completed |
Study Name: Prepubertal Children With Growth Failure Associated With Primary Insulin-Like Growth Factor-1 (IGF-1) Deficiency Condition: Growth Disorders Insulin-Like Growth Factor-1 Deficiency Date: 2005-07-27 Interventions: Drug: rhIGF-1 (mecasermin, Tercica, Inc.) Twice Daily Injection |